• Title of article

    Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V100 superior to D90?

  • Author/Authors

    Michael A. Papagikos، نويسنده , , Allan F. deGuzman، نويسنده , , Peter J. Rossi، نويسنده , , David L. McCullough، نويسنده , , Peter E. Clark، نويسنده , , W. Robert Lee، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2005
  • Pages
    7
  • From page
    252
  • To page
    258
  • Abstract
    Purpose The purpose of the present report is to describe the relationship between two dosimetric quantifiers (V100 and D90) and freedom from biochemical recurrence (FFBR) in a cohort of men treated with low-dose-rate prostate brachytherapy (LDRPB) alone. Methods and materials One hundred three men were treated with LDRPB alone between September 1997 and December 1999. All men had histologically confirmed clinically localized prostate cancer. Fifty-nine percent of the cohort had low-risk disease (defined as PSA <10, Gleason <7, and T stage
  • Keywords
    dosimetry , prostate brachytherapy , 125I , PSA
  • Journal title
    Brachytherapy
  • Serial Year
    2005
  • Journal title
    Brachytherapy
  • Record number

    473907